Search for: "EISAI CO., LTD" Results 21 - 40 of 46
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 May 2007, 1:23 am
DISTRICT COURTSOUTHERN DISTRICT OF NEW YORKIntellectual PropertyCompetitors' Attempts to Market Generic Product Infringed Valid Patent on Drug's Active Ingredient Eisai Co., Ltd. v. [read post]
8 Jul 2009, 7:04 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch) Humira (Adalimumab) – US: Largest patent verdict in history – Abbott to pay $1.67 billion to Centocor because Humira found to… [read post]
15 Sep 2010, 2:40 am by Kelly
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP) US: PHOSITA:… [read post]
28 Dec 2007, 1:00 am
International Trade Commission and Flexsys America: CAFC instructs the ITC on claim construction: (IPBiz), (Patent Prospector), (more from IPBiz)Anonymised net drug sales might yet infringe - Eli Lilly & Company and Lilly Icos LLC v 8PM Chemists Ltd: (IPKat),Open source for cost effective drug discovery: (Spicy IP),Challenges to ethical and generic drug producers: (Profitability through simplicity),US: multiple courts - same patent:… [read post]
14 Jun 2011, 12:21 pm by John Elwood
  The Court GVR’ed with instructions to dismiss as moot in Eisai Co. v. [read post]
7 Jun 2011, 12:30 pm by Christa Culver
Title: Ritchie Special Credit Investments, Ltd. v. [read post]
25 Jul 2008, 7:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC affirms validity and enforceability of Eisai’s compound patent on Aciphex; elucidates current standard for obviousness of chemical composition of matter patents: Eisai v Reddy’s Lab’s and Teva Pharma: (Orange Book Blog), (Patent Docs), (Patent Prospector), (IP Law360), (Hal Wegner), (Patent Baristas),… [read post]